Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Return on Capital Employed: 2022-2025

Historic Return on Capital Employed for Addex Therapeutics (ADXN) over the last 2 years, with Jun 2025 value amounting to -0.31%.

  • Addex Therapeutics' Return on Capital Employed rose 11.00% to -0.31% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.31%, marking a year-over-year increase of 11.00%. This contributed to the annual value of -0.40% for FY2024, which is 27.00% up from last year.
  • Addex Therapeutics' Return on Capital Employed amounted to -0.31% in Q2 2025, which was down 8.73% from -0.28% recorded in Q1 2025.
  • Over the past 5 years, Addex Therapeutics' Return on Capital Employed peaked at 6.72% during Q1 2024, and registered a low of -6.96% during Q1 2023.
  • For the 3-year period, Addex Therapeutics' Return on Capital Employed averaged around -1.24%, with its median value being -0.37% (2024).
  • In the last 5 years, Addex Therapeutics' Return on Capital Employed soared by 1,367bps in 2024 and then tumbled by 700bps in 2025.
  • Addex Therapeutics' Return on Capital Employed (Quarterly) stood at -5.42% in 2022, then skyrocketed by 369bps to -1.73% in 2023, then soared by 148bps to -0.26% in 2024, then climbed by 11bps to -0.31% in 2025.
  • Its last three reported values are -0.31% in Q2 2025, -0.28% for Q1 2025, and -0.26% during Q4 2024.